TW200505468A - Agent for improving hepato-bililary dysfunction - Google Patents
Agent for improving hepato-bililary dysfunctionInfo
- Publication number
- TW200505468A TW200505468A TW093123769A TW93123769A TW200505468A TW 200505468 A TW200505468 A TW 200505468A TW 093123769 A TW093123769 A TW 093123769A TW 93123769 A TW93123769 A TW 93123769A TW 200505468 A TW200505468 A TW 200505468A
- Authority
- TW
- Taiwan
- Prior art keywords
- bililary
- hepato
- improving
- agent
- dysfunction
- Prior art date
Links
- 230000004064 dysfunction Effects 0.000 title abstract 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 abstract 1
- 229920001991 Proanthocyanidin Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Tea And Coffee (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003291779 | 2003-08-11 | ||
| JP2004146961 | 2004-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200505468A true TW200505468A (en) | 2005-02-16 |
Family
ID=34137956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093123769A TW200505468A (en) | 2003-08-11 | 2004-08-09 | Agent for improving hepato-bililary dysfunction |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2005013970A1 (zh) |
| TW (1) | TW200505468A (zh) |
| WO (1) | WO2005013970A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006232752A (ja) * | 2005-02-25 | 2006-09-07 | Tokyo Univ Of Marine Science & Technology | コレステロール及び中性脂肪吸収抑制剤及びこれを含む食品 |
| CN103442709B (zh) * | 2011-03-22 | 2018-10-19 | 财团法人工业技术研究院 | 减缓肝癌恶化、改善肝功能、改善肝纤维化、改善肝硬化、改善肝发炎及促进受损肝脏再生之药物组合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4255336A (en) * | 1977-11-25 | 1981-03-10 | Ciba-Geigy Corporation | Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01 |
| JPH09291039A (ja) * | 1995-12-26 | 1997-11-11 | Suntory Ltd | プロシアニジンを有効成分とする抗肥満剤 |
| US5762936A (en) * | 1996-09-04 | 1998-06-09 | Biotics Research Corporation | Antioxidant derived from lentil and its preparation and uses |
| JP2975997B2 (ja) * | 1998-03-04 | 1999-11-10 | 工業技術院長 | プロアントシアニジンaおよびその誘導体 |
| EP1072265A1 (en) * | 1999-07-20 | 2001-01-31 | MEDIS S.r.l. Medical Infusion Systems | Use of plant polyphenols for treating iron overload |
| JP2003095964A (ja) * | 2001-09-21 | 2003-04-03 | Toyo Shinyaku:Kk | 抗ストレス剤 |
| JP2004123707A (ja) * | 2002-07-29 | 2004-04-22 | Toyo Shinyaku:Kk | 血流改善組成物 |
| JP4499371B2 (ja) * | 2003-01-14 | 2010-07-07 | 株式会社 エフェクト | 落花生由来のプロアントシアニジンの製造方法 |
-
2004
- 2004-08-09 TW TW093123769A patent/TW200505468A/zh unknown
- 2004-08-10 JP JP2005512988A patent/JPWO2005013970A1/ja active Pending
- 2004-08-10 WO PCT/JP2004/011452 patent/WO2005013970A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005013970A1 (ja) | 2005-02-17 |
| JPWO2005013970A1 (ja) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200420573A (en) | Bifunctional heterocyclic compounds and methods of making and using same | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| MXPA03011197A (es) | Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales. | |
| MXPA05007926A (es) | Composiciones herbicidas que contienen aceite de clavo. | |
| WO2004064769A3 (en) | Methods for making and using topical delivery agents | |
| TW200608973A (en) | Rapamycin polymorph Ⅱ and uses thereof | |
| WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
| TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
| MXPA05013553A (es) | Pirrolodihidroisoquinolinas como inhibidores de pde10. | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| AU3652102A (en) | Compounds and their uses | |
| MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
| EP1208085A4 (en) | BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| WO2004014893A3 (en) | Antimicrobial aza-bicyclic derivates, their compositions and uses | |
| MY145074A (en) | Thiazolidin-4-one derivatives | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| TW200800967A (en) | Benzimidazole thiophene compounds | |
| MX2008002492A (es) | Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante. | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| WO2007013666A3 (en) | Anti-tumor agents comprising r-spondins | |
| TW200510398A (en) | Novel compounds | |
| TW200531686A (en) | Pharmaceutical compositions | |
| TW200517117A (en) | Stabilized compositions containing an oxygen-labile active agent |